Global Endocrine Testing Market to Reach $16.9 Billion by 2030
The global market for Endocrine Testing estimated at US$11.4 Billion in the year 2022, is projected to reach a revised size of US$16.9 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2022-2030. Thyroid Stimulating Hormone (TSH) Testing, one of the segments analyzed in the report, is projected to record 5.6% CAGR and reach US$6.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Insulin Testing segment is readjusted to a revised 5.7% CAGR for the next 8-year period.The U.S. Market is Estimated at $3 Billion, While China is Forecast to Grow at 7.8% CAGR
The Endocrine Testing market in the U.S. is estimated at US$3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 4.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR.Select Competitors (Total 31 Featured) -
- AB SCIEX LLC
- Abbott Laboratories, Inc.
- Agilent Technologies, Inc.
- Alfa Aesar, A Thermo Fisher Scientific Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- DiaSorin, Inc.
- F. Hoffmann-La Roche AG
- Laboratory Corporation of America Holdings (LabCorp)
- Ortho-Clinical Diagnostics
- Quest Technology (S) Pte Ltd.
- Sysmex Corporation
- Teleflex Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AB SCIEX LLC
- Abbott Laboratories, Inc.
- Agilent Technologies, Inc.
- Alfa Aesar, A Thermo Fisher Scientific Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- DiaSorin, Inc.
- F. Hoffmann-La Roche AG
- Laboratory Corporation of America Holdings (LabCorp)
- Ortho-Clinical Diagnostics
- Quest Technology (S) Pte Ltd.
- Sysmex Corporation
- Teleflex Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 168 |
Published | March 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 11.4 Billion |
Forecasted Market Value ( USD | $ 16.9 Billion |
Compound Annual Growth Rate | 5.0% |
Regions Covered | Global |